Antibiotic Resistance in Gram Negative Bacteria: An Increasing Issue in Human Health
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (30 September 2022) | Viewed by 464
Special Issue Editor
Interests: bacteriology; antibiotic resistance; mycobacteria; gram-negative bacteria; enterobacteriaceae; colistin resistance; next generation sequencing
Special Issue Information
Dear Colleagues,
Antibiotic resistance is one of the biggest challenges for global health. In human medicine, antibiotic resistance, by delaying effective healthcare, often leads to longer hospital stays, higher medical costs, and increased mortality. If antibiotic resistance is an old phenomenon that occurs naturally, misuse of antibiotics in humans and animals is accelerating the process. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. Fighting antibiotic resistance also requires a better understanding of the factors promoting the transfer of antibiotic resistance. This Special Issue welcomes submissions from different research fields that are describing the evolution, mechanism, and ways to fight antibiotic resistance.
Prof. Dr. Baron Sophie
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotics
- antibiotic resistance
- human health
- antimicrobial
- resistant genes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
